良性甲状腺结节的超声随访:一项范围综述
本范围综述检索至2022年8月的文献,评估细胞学良性且超声低至中度可疑甲状腺结节的最佳超声随访间隔及停止随访的结局。仅纳入一项回顾性队列研究(n=1254;1819个结节),发现首次随访间隔>4年与1–2年相比恶性风险无差异,但>4年随访与结节增长≥50%、重复细针穿刺和甲状腺切除术增加相关。无研究比较停止与继续超声随访。
要点
- 仅一项回顾性队列研究比较了良性甲状腺结节不同超声随访间隔,证据确定性极低。
- 首次随访间隔>4年与1–2年相比恶性风险无差异(0.4% vs 0.3%),无癌症相关死亡。
- >4年随访与结节增长≥50%、重复细针穿刺和甲状腺切除术增加相关。
核心结论
- 比较良性甲状腺结节不同超声随访间隔的证据仅限一项观察性研究,但提示无论随访间隔如何,后续发生甲状腺恶性肿瘤均非常罕见。
- 较长随访可能与更多重复活检和甲状腺切除术相关,这可能与更多间期结节增长达到进一步评估阈值有关。
- 需要研究明确低至中度可疑细胞学良性甲状腺结节的最佳超声随访间隔以及极低可疑结节停止超声随访的结局。
研究设计与样本
- 范围综述,检索Ovid MEDLINE、Embase和Cochrane Central至2022年8月。
- 纳入比较不同超声随访间隔及停止与继续超声随访的研究,人群为细胞学良性且超声极低至中度可疑甲状腺结节患者,主要结局为漏诊甲状腺癌。
- 采用范围综述方法,也纳入未限定于极低至中度可疑超声模式或评估额外结局(如甲状腺癌相关死亡率、结节增长和后续操作)的研究。
- 进行了质量评估,并对证据进行定性综合。
主要发现
- 一项回顾性队列研究(n=1254;1819个结节)比较了细胞学良性甲状腺结节不同首次随访超声间隔。
- 首次随访超声间隔>4年与1–2年相比,恶性可能性无差异(0.4% [1/223] vs 0.3% [2/715]),且无癌症相关死亡发生。
- 随访超声>4年与结节增长≥50%可能性增加相关(35.0% [78/223] vs 15.1% [108/715])。
- 随访超声>4年与重复细针穿刺可能性增加相关(19.3% [43/223] vs 5.6% [40/715])。
- 随访超声>4年与甲状腺切除术可能性增加相关(4.0% [9/223] vs 0.8% [6/715])。
临床怎么用
- 原文未据此给出推荐。
局限性
- 该研究未描述超声模式或控制混杂因素,分析仅基于首次随访超声间隔。
- 其他方法学局限性包括未控制随访时长变异性和失访情况不明确。
- 证据确定性极低。
- 无研究比较停止超声随访与继续随访。
- 需要研究明确低至中度可疑细胞学良性甲状腺结节的最佳超声随访间隔以及极低可疑结节停止超声随访的结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: For cytologically benign thyroid nodules with very low to intermediate suspicion ultrasound patterns, optimal ultrasound follow-up intervals and outcomes of discontinuing follow-up are unclear. Methods: Ovid MEDLINE, Embase, and Cochrane Central were searched through August 2022 for studies comparing different ultrasound follow-up intervals and discontinuation versus continuation of ultrasound follow-up. The population was patients with cytologically benign thyroid nodules and very low to intermediate suspicion ultrasound patterns, and the primary outcome was missed thyroid cancers. Utilizing a scoping approach, we also included studies that were not restricted to very low to intermediate suspicion ultrasound patterns or evaluated additional outcomes such as thyroid cancer-related mortality rate, nodule growth, and subsequent procedures. Quality assessment was performed, and evidence was synthesized qualitatively. Results: One retrospective cohort study (n = 1254; 1819 nodules) compared different first follow-up ultrasound intervals for cytologically benign thyroid nodules. There was no difference between >4- versus 1- to 2-year intervals to first follow-up ultrasound in the likelihood of malignancy (0.4% [1/223] vs. 0.3% [2/715]), and no cancer-related deaths occurred. Follow-up ultrasound at >4 years was associated with increased likelihood of ≥50% nodule growth (35.0% [78/223] vs. 15.1% [108/715]), repeat fine needle aspiration (19.3% [43/223] vs. 5.6% [40/715]), and thyroidectomy (4.0% [9/223] vs. 0.8% [6/715]). The study did not describe ultrasound patterns or control for confounders, and analyses were based on interval to first follow-up ultrasound only. Other methodological limitations were not controlling for variability in follow-up duration and unclear attrition. The certainty of evidence was very low. No study compared discontinuation of ultrasound follow-up versus continuation. Conclusions: This scoping review found that evidence comparing different ultrasound follow-up intervals in patients with benign thyroid nodules is limited to one observational study, but suggests that the subsequent development of thyroid malignancies is very uncommon regardless of follow-up interval. Longer follow-up may be associated with more repeat biopsies and thyroidectomies, which could be related to more interval nodule growth that meets thresholds for further evaluation. Research is needed to clarify optimal ultrasound follow-up intervals for low to intermediate suspicion cytologically benign thyroid nodules and outcomes of discontinuing ultrasound follow-up for very low suspicion nodules.
引用
- Chou R, Dana T, Mayson SE, et al. Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review. Thyroid. 2023. PMID: 36800900. doi:10.1089/thy.2022.0692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。